Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.965 USD | -2.15% | +23.22% | -28.00% |
01:01pm | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
05-10 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.00% | 402M | |
+23.21% | 44.96B | |
+0.55% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+11.03% | 26.08B | |
-21.26% | 19.03B | |
+6.29% | 12.75B | |
+28.78% | 12.06B | |
-3.45% | 11.75B |
- Stock Market
- Equities
- ORGO Stock
- News Organogenesis Holdings Inc.
- Morgan Stanley Adjusts Price Target on Organogenesis Holdings to $3 From $5, Maintains Equal-Weight Rating